Cognitive impairment in schizophrenia across age groups: A case-control study

BMC Psychiatry

Volumn 16, Issue 1, 2016, Pages

  Mosiołek, Anna ^a   Gierus, Jacek ^a   Koweszko, Tytus ^a   Szulc, Agata ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Cognitive impairment; Executive functions; Schizophrenia

Indexed keywords

CHLORPROMAZINE;

ADULT; AGE; ARTICLE; CASE CONTROL STUDY; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; EXECUTIVE FUNCTION; FEMALE; FLUENCY DISORDER; HUMAN; LEARNING DISORDER; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MIDDLE AGED; REY AUDITORY VERBAL LEARNING TEST; REY OSTERRIETH COMPLEX FIGURE TEST; SCHIZOPHRENIA; STROOP TEST; TRAIL MAKING TEST; WISCONSIN CARD SORTING TEST; YOUNG ADULT; COGNITION DISORDERS; COMPARATIVE STUDY; COMPLICATION; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGY; PSYCHOTIC DISORDERS; STATISTICS AND NUMERICAL DATA;

ADULT; AGE FACTORS; CASE-CONTROL STUDIES; COGNITION; COGNITION DISORDERS; EXECUTIVE FUNCTION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STROOP TEST;

EID: 84959082558     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/s12888-016-0749-1     Document Type: Article

References (44)

1. Andreasen NC. An unitary model of schizophrenia. Bleuler's 'fragmented phrene' as schizencephaly. Arch Gen Psychiatry. 1999;56:781-7.
2. Andreasen NC, Nopoulos P, O'Leary DS, Miller DD, Wassink T, Flaum M. Defining the phenotype of schizophrenia: cognitive dysmetria and its neural mechanisms. Biol Psychiatry. 1999;46:908-20.
3. Green MF, Kern RS, Heaton RK. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res. 2004;72:41-51.
4. Lencz T, Knowles E, Davies G, Guha S, Liewald DC, Starr JM, Djurovic S, Melle I, Sundet K, Christoforou A, Reinvang I, Mukherjee S, DeRosse P, Lundervold A, Steen VM, John M, Espeseth T, Räikkönen K, Widen E, Palotie A, Eriksson JG, Giegling I, Konte B, Ikeda M, Roussos P, Giakoumaki S, Burdick KE, Payton A, Ollier W, Horan M, Donohoe G, Morris D, Corvin A, Gill M, Pendleton N, Iwata N, Darvasi A, Bitsios P, Rujescu D, Lahti J, Hellard SL, Keller MC, Andreassen OA, Deary IJ,n Glahn DC, Malhotra AK. Molecular genetic evidence for overlap between general cognitive ability and risk for schizophrenia: a report from the Cognitive Genomics consorTium (COGENT). Mol Psychiatry. 2014;19, 168-174.
5. Fisher M, Loewy R, Hardy K, Schlosser D, Vinogradov S. Cognitive interventions targeting brain plasticity in the prodromal and early phases of schizophrenia. Annu Rev Clin Psychol. 2013;9:435-63.
6. Andreasen NC, Grove WM. Thought, language, and communication in schizophrenia: diagnosis and prognosis. Schizoph Bull. 1986;12:348-59.
7. Gold S, Arndt S, Nopoulos P, O'Leary DS, Andreasen NC. Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. Am J Psychiatry. 1999;156:1342-8.
8. Stahl SM: Essential Psychopharmacology: The Prescriber's Guide: Revised and Updated Edition (Essential Psychopharmacology Series). Cambridge, UK: Cambridge University Press, 2004a.
9. Stahl SM: Symptoms and circuits, part 3: schizophrenia. J Clin Psychiatry 2004b; 65: 8-9.
10. Kontaxaki MI, Kattoulas E, Smyrnis N, Stefanis NC. Cognitive impairments and psychopathological parameters in patients of the schizophrenic spectrum. Psychiatrike. 2014;25:27-38.
11. Goldberg T, Weinberger D, Pliskin N, Berman K, Podd H. Recall memory deficit in schizophrenia: a possible manifestation of prefrontal dysfunction. Schizophr Res. 1989;72:41-51.
12. Balzan RP, Neaves A, Denson LA, Liu D, Galletly C. Cognitive deficit awareness in schizophrenia: absent, intact, or somewhere in-between? Cogn Neuropsychiatry. 2014;22:1-14.
13. Kuperberg G, Heckers S. Schizophrenia and cognitive function. Curr Opin Neurobiol. 2000;10:205-10.
14. Gold JM. Cognitive deficits as treatment targets in schizophrenia. Schizophr Res. 2004;72:21-8.
15. Dickinson D, Ragland JD, Gold JM, Gur RC. General and specific cognitive deficits in schizophrenia: Goliath defeats David? Biol. Psychiatry. 2008;64:823-7.
16. Riley E, McGovern D, Mocler D, Doku VCK, Óceallaigh S, Fannan DG, et al. Neuropsychological functioning in first episode psychosis-evidence of specyfic deficits. Schizophr Res. 2000;43:47-55.
17. Lencz T, Smith CW, McLaughlin D, Auther A, Nakayama E, Hovey L, et al. Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biol Psychiatry. 2006;59:863-71.
18. Simon AE, Cattapan-Ludewig K, Zmilacher S, Arbach D, Gruber K, Dvorsky DN, et al. Cognitive functioning in the schizophrenia prodrome. Schizophr Bull. 2007;33:761-71.
19. Seidman LJ, Giuliano AJ, Meyer EC, Addington J, Cadenhead KS, Cannon TD, et al. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Arch Gen Psychiatry. 2010;67:578-88.
20. Lewandowski KE, Cohen BM, Ongur D. Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder. Psychol Med. 2011;41:225-41.
21. Karageorgiou E, Schulz SC, Gollub RL, Andreasen NC, Ho BC, Lauriello J, et al. Neuropsychological testing and structural magnetic resonance imaging as diagnostic biomarkers early in the course of schizophrenia and related psychoses. Neuroinformatics. 2011;9:321-33.
22. Olney JW. New insights and new issues in developmental neurotoxicology. Neurotoxicology. 2002;23:659-68.
23. Gargiulo PA, Landa De Gargiulo AL. Glutamate and modeling of schizophrenia symptoms: Review of our Findings: 1990-2014. Pharmacol Rep. 2014;66:343-52.
24. Milev P, Ho BC, Arndt S, Nopoulos P, Andreasen NC. Initial magnetic resonance imaging volumetric brain measurements and outcome in schizophrenia: a prospective longitudinal study with 5-year follow-up. Biol Psychiatry. 2003;54:608-15.
25. Andreasen NC, Nopoulos P, Magnotta V, Pierson R, Ziebell S, Ho BC. Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia. Biol Psychiatry. 2011;70:672-9.
26. Andreasen NC, Liu D, Ziebell S, Vora A, Ho BC. Relapse duration, treatment intensity, and brain tissue loss in schizophrenia: a prospective longitudinal MRI study. Am J Psychiatry. 2013;170:609-15.
27. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) Fourth, Text Revision. Washington: APA; 2000.
28. Zipursky RB, Reilly TJ, Murray RM. The myth of schizophrenia as a progressive brain disease. Schizophr Bull. 2013;39:1363-72.
29. Lysaker PH, Glynn SM, Wilkniss SM, Silverstein SM: Psychotherapy and recovery from schizophrenia: A review of potential applications and need for future study. Psychol Serv. 2010;7:75-91.
30. Wykes T, Huddy V, Cellard C, McGurk SR, Czobor P. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatry. 2011;168:472-85.
31. McGurk SR, Twamley EW, Sitzer DI, McHugo GJ, Mueser KT. A meta-analysis of cognitive remediation in schizophrenia. Am J Psychiatry. 2007;164:1791-802.
32. Kay S, Fiszbin A, Opler L. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizoph Bull. 1987;13:261-76.
33. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Brit J Psychiat. 1979;134:382-9.
34. Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtis G. Wisconsin Card Sorting Test (WCST) manual: revised and expanded. Odessa: Psychological Assessment Resources Inc.; 1993.
35. Reitan RM. Validity of the Trail Making Test as an indicator of organic brain damage. Percept Mot Skills. 1958;8:271-6.
36. Vinogradov S, Fisher M, Nagarajan S. Cognitive training in schizophrenia: golden age or wild west? Biol Psychiatry. 2013;73:935-7.
37. Bagney A, Rodriguez-Jimenez R, Martinez-Gras I, Sanchez-Morla EM, Santos JL, Jimenez-Arriero MA, et al. Negative symptoms and executive function in schizophrenia: does their relationship change with illness duration? Psychopathology. 2013;46:241-8.
38. Bozikas VP, Kosmidis MH, Kioperlidou K, Karavatos A. Relationship between psychopatology and cognitive functioning in schizophrenia. Compr Psychiat. 2004;45:392-400.
39. Addington J, Addington D. Cognitive functioning in first-episode schizophrenia. J Psychiatry Neurosci. 2011;27:188-92.
40. de Vries PJ, Honer WG, Kemp PM, McKenna PJ. Dementia as a complication of schizophrenia. J Neurol Neurosurg Psychiatry. 2001;70:588-96.
41. Heaton RK, Gladsjo JA, Palmer BW, Kuck J, Marcotte TD, Jeste DV. Stability and course of neuropsychological deficits in schizophrenia. Arch Gen Psychiatry. 2001;58:24-32.
42. Loewenstein DA, Czaja SJ, Bowie CR, Harvey PD. Age-associated differences in cognitive performance in older patients with schizophrenia: a comparison with healthy older adults. Am J Geriat Psychiat. 2012;20:29-40.
43. Zipursky RB. Why are the outcomes in patients with schizophrenia so poor? J Clin Psychiatry. 2014;75:20-4.
44. McCleery A, Ventura J, Kern RS, Subotnik KL, Gretchen-Doorly D, Green MF, Hellemann GS, Nuechterlein KH: Cognitive functioning in first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) Profile of Impairment. Schizophr Res. 10.1016/j.schres.2014.04.039